The Food and Drug Administration has approved Shire's Daytrana skin patch to treat patients ages 13 to 17 who have attention-deficit/hyperactivity disorder. The treatment is already available for children ages 6 to 12 with ADHD.
Published in Brief:
|San Francisco Unified is Accepting Applications for 2015-16!||
San Francisco Unified School District
|San Francisco, CA|
|Director of Professional Services||
Engaging Schools, Inc.
|Principal at Emerson Academy of Dayton||
National Heritage Academies
|Program Officer, Teacher Development||
Knowles Science Teaching Foundation
|Senior Researcher (8194)||
American Institute for Researcher